Compare · BLCO vs WRBY
BLCO vs WRBY
Side-by-side comparison of Bausch + Lomb Corporation (BLCO) and Warby Parker Inc. (WRBY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BLCO and WRBY operate in Ophthalmic Goods (Health Care), so they compete in similar markets.
- BLCO is the larger of the two at $5.80B, about 1.7x WRBY ($3.42B).
- Over the past year, BLCO is up 18.7% and WRBY is up 21.7% - WRBY leads by 2.9 points.
- WRBY has been more active in the news (9 items in the past 4 weeks vs 3 for BLCO).
- WRBY has more recent analyst coverage (25 ratings vs 18 for BLCO).
- Company
- Bausch + Lomb Corporation
- Warby Parker Inc.
- Price
- $16.29+1.94%
- $27.89+1.01%
- Market cap
- $5.80B
- $3.42B
- 1M return
- +7.88%
- +5.42%
- 1Y return
- +18.73%
- +21.66%
- Industry
- Ophthalmic Goods
- Ophthalmic Goods
- Exchange
- NYSE
- NYSE
- IPO
- 2022
- 2021
- News (4w)
- 3
- 9
- Recent ratings
- 18
- 25
Bausch + Lomb Corporation
Bausch + Lomb Corporation operates as an eye health company in Canada and internationally. It operates through three segments: Vision Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that cover the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions. It offers intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.
Warby Parker Inc.
Warby Parker Inc. designs, manufactures, and retails eyewear products for men and women. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses, as well as eye exams and vision tests. As of June 30, 2021, it operated 145 retail stores, which included 142 locations in the United States and 3 locations in Canada, as well as online stores. The company was formerly known as JAND, Inc. and changed its name to Warby Parker Inc. in June 2021. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.
Latest BLCO
- Bausch + Lomb Announces Phase 2 Results for Glaucoma Neuroprotective Candidate
- Bausch + Lomb Introduces Orphia™, an AI-Powered Digital Health Platform Built to Return Physicians to Patient Care
- Bausch + Lomb Will Release Second-Quarter 2026 Financial Results on July 29
- President, Surgical Bonnefoy Luc covered exercise/tax liability with 1,008 shares, decreasing direct ownership by 1% to 87,023 units (SEC Form 4) to satisfy tax liability
- SEC Form SD filed by Bausch + Lomb Corporation
- Bausch + Lomb Launches Blink® Triple Care Preservative Free Lubricant Eye Drops in the United States
- Director Von Eschenbach Andrew C. was granted 15,842 shares, increasing direct ownership by 22% to 86,656 units (SEC Form 4)
- Director Ross Thomas W. Sr. was granted 15,842 shares, increasing direct ownership by 23% to 85,233 units (SEC Form 4)
- Director Robertson Russel C was granted 15,842 shares, increasing direct ownership by 20% to 94,260 units (SEC Form 4)
- Director Paulson John was granted 15,842 shares, increasing direct ownership by 21% to 89,823 units (SEC Form 4)
Latest WRBY
- Co-Chief Executive Officer Blumenthal Neil Harris converted options into 9,200 shares and sold $275,908 worth of shares (9,200 units at $29.99) as part of a pre-agreed trading plan (SEC Form 4)
- Co-Chief Executive Officer Gilboa David Abraham converted options into 54,347 shares and sold $1,621,714 worth of shares (54,347 units at $29.84) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 144 filed by Warby Parker Inc.
- Co-Chief Executive Officer Blumenthal Neil Harris converted options into 189,320 shares and sold $6,445,120 worth of shares (217,667 units at $29.61) as part of a pre-agreed trading plan, decreasing direct ownership by 48% to 31,112 units (SEC Form 4)
- Co-Chief Executive Officer Gilboa David Abraham converted options into 213,746 shares and sold $7,191,541 worth of shares (242,221 units at $29.69) as part of a pre-agreed trading plan, decreasing direct ownership by 48% to 31,112 units (SEC Form 4)
- Director Raider Jeffrey Jacob sold $668,700 worth of shares (22,500 units at $29.72) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 435,201 units (SEC Form 4)
- Co-Chief Executive Officer Blumenthal Neil Harris converted options into 36,300 shares and sold $1,090,452 worth of shares (36,300 units at $30.04) as part of a pre-agreed trading plan (SEC Form 4)
- BofA Securities initiated coverage on Warby Parker with a new price target
- SEC Form 4 filed by Co-Chief Executive Officer Blumenthal Neil Harris
- Director Briggs Teresa sold $129,683 worth of shares (5,000 units at $25.94) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 48,883 units (SEC Form 4)